{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:26:04Z","timestamp":1788906364638,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cca.2026.121179","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:54:10Z","timestamp":1781312050000},"page":"121179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Erythroferrone in \u03b2-thalassemia: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"591","author":[{"given":"Muhammad","family":"Saboor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Abass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121179_bb0005","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2025.2551450","article-title":"The disease burden of \u03b2-thalassaemia revisited","volume":"30","author":"Soteriades","year":"2025","journal-title":"Hematology"},{"key":"10.1016\/j.cca.2026.121179_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2023.1187681","article-title":"Global burden and unmet needs in the treatment of transfusion-dependent \u03b2-thalassemia","volume":"2","author":"Forni","year":"2023","journal-title":"Front. Hematol."},{"key":"10.1016\/j.cca.2026.121179_bb0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra2021838","article-title":"\u03b2-thalassemias","volume":"384","author":"Taher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.121179_bb0020","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1182\/blood-2006-09-048868","article-title":"Ineffective erythropoiesis in \u03b2-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin","volume":"109","author":"Gardenghi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121179_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1749-6632.2010.05585.x","article-title":"Hepcidin in \u03b2-thalassemia","volume":"1202","author":"Nemeth","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2026.121179_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10010189","article-title":"Activation of STAT and SMAD signaling induces hepcidin re-expression as a therapeutic target for \u03b2-thalassemia patients","volume":"10","author":"Saad","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121179_bb0035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cca.2026.121179_bb0040","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2018-06-857995","article-title":"Erythroferrone inhibits the induction of hepcidin by BMP6","volume":"132","author":"Arezes","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121179_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/joah.joah_10_26","article-title":"Serum erythroferrone level and its relation to iron overload in patients with beta-thalassemia","volume":"17","author":"Salama","year":"2026","journal-title":"J. Appl. Hematol."},{"key":"10.1016\/j.cca.2026.121179_bb0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/03630269.2026.2637574","article-title":"Comparative analysis of erythroferrone and hepcidin as emerging biomarkers of iron homeostasis in patients with \u03b2-thalassemia major: a case-control study from Pakistan","volume":"50","author":"Babar","year":"2026","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cca.2026.121179_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2025.127591","article-title":"Deciphering the role of hepcidin in iron metabolism and anemia management","volume":"87","author":"Kesharwani","year":"2025","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.cca.2026.121179_bb0060","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1002\/jcp.30247","article-title":"Erythroferrone structure, function, and physiology: Iron homeostasis and beyond","volume":"236","author":"Srole","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cca.2026.121179_bb0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.2021014326","article-title":"Erythroferrone in iron regulation and beyond","volume":"139","author":"Babitt","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121179_bb0070","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2026.121179_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.cca.2026.121179_bb0080","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ajh.27102","article-title":"Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia","volume":"99","author":"Garbowski","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2026.121179_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254851","article-title":"Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone","volume":"16","author":"Diepeveen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.121179_bb0090","series-title":"Journal of Physics: Conference Series","article-title":"Erythroferrone hormone a novel biomarker is associated with anemia and iron overload in beta thalassemia patients","author":"Almousawi","year":"2019"},{"key":"10.1016\/j.cca.2026.121179_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/ejh.ejh_22_21","article-title":"Serum erythroferrone diagnostic value in patients with beta-thalassemia with iron overload","volume":"46","author":"Saeed","year":"2021","journal-title":"Egyptian J. Haematol."},{"key":"10.1016\/j.cca.2026.121179_bb0100","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41390-023-02729-5","article-title":"The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients","volume":"95","author":"Youssry","year":"2024","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cca.2026.121179_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000627","article-title":"A comprehensive analysis of the erythropoietin-erythroferrone-hepcidin pathway in hereditary hemolytic anemias","volume":"5","author":"Van Vuren","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.cca.2026.121179_bb0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/03630269.2020.1794888","article-title":"Evaluation of erythroferrone, hepcidin, and Iron overload status in Iraqi transfusion-dependent \u03b2-thalassemia major patients","volume":"44","author":"Smesam","year":"2020","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cca.2026.121179_bb0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/joah.joah_68_25","article-title":"Role of erythroferrone and hepcidin in iron overload and correlation with hepatic fibrosis complications in beta-thalassemia major pediatric patients","volume":"16","author":"Khalaf","year":"2025","journal-title":"J. Appl. Hematol."},{"key":"10.1016\/j.cca.2026.121179_bb0120","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4103\/ejh.ejh_28_25","article-title":"Erythroferrone as iron overload biomarker in thalassemic patients: a case control study","volume":"50","author":"Abido","year":"2025","journal-title":"Egyptian J. Haematol."},{"key":"10.1016\/j.cca.2026.121179_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MPH.0000000000002046","article-title":"Erythropoiesis and iron parameters in transfusion-dependent and nontransfusion-dependent thalassemias","volume":"43","author":"Ozturk","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.cca.2026.121179_bb0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/bjh.18619","article-title":"The effect of erythroferrone suppression by transfusion on the erythropoietin\u2013erythroferrone\u2013hepcidin axis in transfusion-dependent thalassaemia: a pre\u2013post cohort study","volume":"201","author":"Zaman","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2026.121179_bb0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1182\/blood-2012-12-471441","article-title":"Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with \u03b2-thalassemia major: a longitudinal study","volume":"122","author":"Pasricha","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121179_bb0140","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.3512","article-title":"Transforming growth factor-\u03b2 superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis","volume":"20","author":"Suragani","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2026.121179_bb0145","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","article-title":"A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia","volume":"382","author":"Cappellini","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.121179_bb0150","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2015-07-658419","article-title":"Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of \u03b2-thalassemia","volume":"26","author":"Kautz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121179_bb0155","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000732","article-title":"2021 thalassaemia international federation guidelines for the management of transfusion-dependent thalassemia","volume":"6","author":"Farmakis","year":"2022","journal-title":"Hemasphere"},{"key":"10.1016\/j.cca.2026.121179_bb0160","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","article-title":"A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia","volume":"107","author":"Cappellini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121179_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22020873","article-title":"The oral ferroportin inhibitor VIT-2763 improves erythropoiesis without interfering with iron chelation therapy in a mouse model of \u03b2-thalassemia","volume":"22","author":"Nyffenegger","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121179_bb0170","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"Weatherall","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121179_bb0175","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1629","article-title":"High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin","volume":"13","author":"Tanno","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2026.121179_bb0180","first-page":"184","article-title":"Growth differentiation factor 15 in erythroid health and disease","volume":"17","author":"Tanno","year":"2010","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cca.2026.121179_bb0185","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3324\/haematol.10842","article-title":"Liver iron concentrations and urinary hepcidin in beta-thalassemia","volume":"92","author":"Origa","year":"2007","journal-title":"Haematologica"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812600361X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812600361X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:17:04Z","timestamp":1786421824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989812600361X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S000989812600361X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121179","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythroferrone in \u03b2-thalassemia: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121179"}}